BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 30859228)

  • 1. Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction.
    Herring N; Tapoulal N; Kalla M; Ye X; Borysova L; Lee R; Dall'Armellina E; Stanley C; Ascione R; Lu CJ; Banning AP; Choudhury RP; Neubauer S; Dora K; Kharbanda RK; Channon KM;
    Eur Heart J; 2019 Jun; 40(24):1920-1929. PubMed ID: 30859228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide-Y Levels in ST-Segment-Elevation Myocardial Infarction: Relationship With Coronary Microvascular Function, Heart Failure, and Mortality.
    Gibbs T; Tapoulal N; Shanmuganathan M; Burrage MK; Borlotti A; Banning AP; Choudhury RP; Neubauer S; Kharbanda RK; Ferreira VM; Channon KM; Herring N;
    J Am Heart Assoc; 2022 Jul; 11(13):e024850. PubMed ID: 35766271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of plasma neuropeptide Y with angiographic, electrocardiographic and coronary physiology indices of reperfusion during ST elevation myocardial infarction.
    Cuculi F; Herring N; De Caterina AR; Banning AP; Prendergast BD; Forfar JC; Choudhury RP; Channon KM; Kharbanda RK
    Heart; 2013 Aug; 99(16):1198-203. PubMed ID: 23403409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Predictive Value of Microvascular Flow Abnormalities after Successful Contemporary Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction.
    Aggarwal S; Xie F; High R; Pavlides G; Porter TR
    J Am Soc Echocardiogr; 2018 Jun; 31(6):674-682. PubMed ID: 29525249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade.
    Kalla M; Hao G; Tapoulal N; Tomek J; Liu K; Woodward L; ; Dall'Armellina E; Banning AP; Choudhury RP; Neubauer S; Kharbanda RK; Channon KM; Ajijola OA; Shivkumar K; Paterson DJ; Herring N
    Eur Heart J; 2020 Jun; 41(23):2168-2179. PubMed ID: 31834357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvascular obstruction extent predicts major adverse cardiovascular events in patients with acute myocardial infarction and preserved ejection fraction.
    Galea N; Dacquino GM; Ammendola RM; Coco S; Agati L; De Luca L; Carbone I; Fedele F; Catalano C; Francone M
    Eur Radiol; 2019 May; 29(5):2369-2377. PubMed ID: 30552479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zero-Flow Pressure Measured Immediately After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Provides the Best Invasive Index for Predicting the Extent of Myocardial Infarction at 6 Months: An OxAMI Study (Oxford Acute Myocardial Infarction).
    Patel N; Petraco R; Dall'Armellina E; Kassimis G; De Maria GL; Dawkins S; Lee R; Prendergast BD; Choudhury RP; Forfar JC; Channon KM; Davies J; Banning AP; Kharbanda RK
    JACC Cardiovasc Interv; 2015 Sep; 8(11):1410-1421. PubMed ID: 26404192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute coronary blood flow measurement and microvascular resistance in ST-elevation myocardial infarction in the acute and subacute phase.
    Wijnbergen I; van 't Veer M; Lammers J; Ubachs J; Pijls NH
    Cardiovasc Revasc Med; 2016 Mar; 17(2):81-7. PubMed ID: 26905054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of microvascular function in patients presenting with thrombolysis for ST elevation myocardial infarction, and PCI for non-ST elevation myocardial infarction.
    Palmer S; Layland J; Adams H; Ashokkumar S; Williams PD; Judkins C; La Gerche A; Burns AT; Whitbourn RJ; MacIsaac AI; Wilson AM
    Cardiovasc Revasc Med; 2018 Dec; 19(8):917-922. PubMed ID: 29709534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiography-derived index of microcirculatory resistance as a novel, pressure-wire-free tool to assess coronary microcirculation in ST elevation myocardial infarction.
    De Maria GL; Scarsini R; Shanmuganathan M; Kotronias RA; Terentes-Printzios D; Borlotti A; Langrish JP; Lucking AJ; Choudhury RP; Kharbanda R; Ferreira VM; ; Channon KM; Garcia-Garcia HM; Banning AP
    Int J Cardiovasc Imaging; 2020 Aug; 36(8):1395-1406. PubMed ID: 32409977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of neuropeptide Y on coronary artery vasomotion in patients with microvascular angina.
    Rosano GMC; Tousoulis D; McFadden E; Clarke J; Davies GJ; Kaski JC
    Int J Cardiol; 2017 Jul; 238():123-127. PubMed ID: 28476516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of plasma neuropeptide-Y with myocardial function and infarct severity in acute ST-elevation myocardial infarction.
    Tiller C; Reindl M; Holzknecht M; Lechner I; Troger F; Oberhollenzer F; von der Emde S; Kremser T; Mayr A; Bauer A; Metzler B; Reinstadler SJ
    Eur J Intern Med; 2024 Mar; ():. PubMed ID: 38555253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodilution-derived coronary blood flow pattern immediately after coronary intervention as a predictor of microcirculatory damage and midterm clinical outcomes in patients with ST-segment-elevation myocardial infarction.
    Fukunaga M; Fujii K; Kawasaki D; Sawada H; Miki K; Tamaru H; Imanaka T; Iwasaku T; Nakata T; Shibuya M; Akahori H; Masutani M; Kobayashi K; Ohyanagi M; Masuyama T
    Circ Cardiovasc Interv; 2014 Apr; 7(2):149-55. PubMed ID: 24550440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early change in invasive measures of microvascular function can predict myocardial recovery following PCI for ST-elevation myocardial infarction.
    Cuculi F; Dall'Armellina E; Manlhiot C; De Caterina AR; Colyer S; Ferreira V; Morovat A; Prendergast BD; Forfar JC; Alp NJ; Choudhury RP; Neubauer S; Channon KM; Banning AP; Kharbanda RK
    Eur Heart J; 2014 Aug; 35(29):1971-80. PubMed ID: 24135835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Dynamic Relationship Between Invasive Microvascular Function and Microvascular Injury Indicators, and Their Association With Left Ventricular Function and Infarct Size at 1-Month After Reperfused ST-Segment-Elevation Myocardial Infarction.
    Demirkiran A; Robbers LFHJ; van der Hoeven NW; Everaars H; Hopman LHGA; Janssens GN; Berkhof HJ; Lemkes JS; van de Bovenkamp AA; van Leeuwen MAH; Nap A; van Loon RB; de Waard GA; van Rossum AC; van Royen N; Nijveldt R
    Circ Cardiovasc Interv; 2022 Nov; 15(11):892-902. PubMed ID: 36305318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between admission Q waves and microvascular injury in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Tiller C; Reindl M; Holzknecht M; Innerhofer L; Wagner M; Lechner I; Mayr A; Klug G; Bauer A; Metzler B; Reinstadler SJ
    Int J Cardiol; 2019 Dec; 297():1-7. PubMed ID: 31629564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of the Thermodilution-Derived Index of Microcirculatory Resistance and Coronary Flow Reserve Is Highly Predictive of Microvascular Obstruction on Cardiac Magnetic Resonance Imaging After ST-Segment Elevation Myocardial Infarction.
    Ahn SG; Hung OY; Lee JW; Lee JH; Youn YJ; Ahn MS; Kim JY; Yoo BS; Lee SH; Yoon J; Kwon W; Samady H
    JACC Cardiovasc Interv; 2016 Apr; 9(8):793-801. PubMed ID: 27017370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental Value of Coronary Microcirculation Resistive Reserve Ratio in Predicting the Extent of Myocardial Infarction in Patients with STEMI. Insights from the Oxford Acute Myocardial Infarction (OxAMI) Study.
    Scarsini R; De Maria GL; Borlotti A; Kotronias RA; Langrish JP; Lucking AJ; Choudhury RP; Ferreira VM; Ribichini F; Channon KM; Kharbanda RK; Banning AP
    Cardiovasc Revasc Med; 2019 Dec; 20(12):1148-1155. PubMed ID: 30797759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemia From Nonculprit Stenoses Is Not Associated With Reduced Culprit Infarct Size in Patients with ST-Segment-Elevation Myocardial Infarction.
    Ekström K; Nielsen JVW; Nepper-Christensen L; Ahtarovski KA; Kyhl K; Göransson C; Bertelsen L; Ghotbi AA; Kelbæk H; Høfsten DE; Køber L; Schoos MM; Vejlstrup N; Lønborg J; Engstrøm T
    Circ Cardiovasc Imaging; 2021 May; 14(5):e012290. PubMed ID: 33951923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.